Amyotrophic lateral sclerosis (ALS), alternatively known as Lou Gehrig’s disease is a motor neuron disease that is caused by the degeneration of the motor neurons, which results in the development of muscular atrophy, and the eventual loss of control over actions such as breathing, swallowing and speaking. Today, approximately 30,000 people in the United States are affected by ALS, with 5,000 new cases being diagnosed per year. Currently, there is no cure for ALS, but there are several organizations that are working to change this.
One such organization is Prize4Life, a non-profit organization that was founded in 2006 by students of Harvard Business School, after one of them, Avichai Kremer, was diagnosed with ALS at age 29. Prize4Life is dedicated to advancing research on effective cures and treatments for ALS and to raising awareness on ALS to as many people as possible.
On June 24, Prize4Life is hosting their annual Prize4Life Gala, which brings together multifaceted companies and individuals for one night to support the battle against ALS. The Gala will also honor three distinguished people who have each made significant contributions to advancing efforts to combat ALS. The first award, the Prize4Life Pioneer Award for ALS Research, will be bestowed upon Biogen Idec Inc., an American biotechnology company. The second award, the Prize4Life Courage Award, will be presented to Prize4Life Board Member and ALS patient George Mazareas and his wife Cynthia Mazareas for the inspirational roles they have played in Prize4Life’s initiatives.
The night will commence at 6:30 p.m. with cocktails, followed by dinner at 7:30 p.m.
Prize4Life acknowledges that ALS is an illness that targets no obvious race, nationality or gender. They work to reduce the number of deaths due to ALS and increase the number of days those who are diagnosed have, past 1,000 days. Their programs work to save the lives of not only the 30,000 people living with ALS in the United States, but also the hundreds of thousands of people living with it around the globe, an initiative that is definitely worth supporting.
WHEN: Monday, June 24, 2013 at 6:30 p.m.